Surge Private Equity Invests in Elite Clinical Network

September 8, 2023

Dallas-based Surge Private Equity formed a strategic partnership and majority investment in Elite Clinical Network (ECN), an integrated operator of phase I–IV clinical research sites across California, Arizona and Nevada. The transaction was valued at roughly $200 million and closed with debt financing provided by affiliates of MGG Investment Group LP to support ECN’s national expansion and site growth.

Buyers
Surge Private Equity, LLC, MGG Investment Group LP
Targets
Elite Clinical Network, LLC
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.